Fendexam 20 mg Tablet
PDF Leaflet Revision Date: 09 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of breast cancer.
Dosage (summary)
20 mg to 40 mg daily, in divided doses or as a single dose.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; potential risks to fetus.
Key Drug Interactions
- Warfarin
- CYP2D6 inhibitors
- Cytotoxic medicines
Contraindications
- Hypersensitivity to tamoxifen
- Pregnancy
- Breastfeeding
- Concomitant coumarin anticoagulants
Common side effects
- Hot flushes
- Menstrual irregularities
- Nausea
- Fatigue
Counselling Points
- Avoid pregnancy during treatment
- Monitor for abnormal gynaecological symptoms
- Report any visual disturbances
Serious warnings
- Increased risk of thromboembolic events
- Endometrial cancer risk
- Liver enzyme changes
Important Disclaimer
The Fendexam 20 mg Tablet professional information leaflet below is the property of Aurogen Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
